Epigenetic Therapies Could Modulate EGFR Amplification, Effecting Therapeutic Response
PHILADELPHIA (November 27, 2019) – Prolonged treatment with EGFR inhibitors can reduce the copies of EGFR, leading to therapy resistance, according to Johnathan R. Whetstine, PhD. Whetstine, the study’s corresponding author.